Drug shortages to treat hepatitis discovered

Friday 28 July is World Hepatitis Day, with 296 million people living with the disease in 2019, according to the World Health Organization.In addition, each year there are 1.5 million new infections. For more information, in 2019, hepatitis B caused approximately 820,000 deaths, mostly from cirrhosis or hepatocellular carcinoma (primary liver cancer).

Therefore, within the framework of this international event, the LUDA Partners Digital Pharmacy Network, the only one with these characteristics, present in all the provinces of Spain and with more than 3,300 affiliated pharmacies, takes this opportunity to convey that it has determined new supply problem Different medicines used to treat this disease.

In this sense, some of the drugs with the most complications are for hospital use, such as entecavir (used to treat chronic infections) Hepatitis B adults with liver damage and children over two years of age) and lamivudine (to treat hepatitis B infection in people with liver damage that is not functioning properly).

In addition to the clinical manifestations arising from the disease itself, viral hepatitis can produce or exacerbate a range of problems in patients, especially those related to: overweight and diabetes. In this sense, there is a problem with the availability of drugs used to treat these diseases, which are dispensed from pharmacies rather than hospitals.

It is in this scenario that the cooperation of pharmacies is so necessary.Thanks to a 100% technological solution, patients can go to a reference pharmacy and if there are supply issues with such treatments, pharmacists can can be located Instantly provide solutions by searching for these missing drugs in LUDA tool.

For example, hepatitis C virus infection, in particular, can promote the development of diabetes. In such cases, doctors may prescribe medications such as Ozempic or Saxenda, which also have supply issues. Specifically, they provide the following services:

  • ozone (0.25 mg, 0.5 mg, or 1 mg solution for injection) is a medicine used to treat type 2 diabetes and to help with weight loss.
  • Saxonda (6mg/ml solution for injection) is used to regulate appetite, eliminate satiety, and balance blood sugar.

Also, another drug that is hardest to find in Spanish pharmacies is:

  • Legron SIL 350 mg lyophilized for infusion solution (AEMPS authorized unit for special commercialization as no expected recovery date). It is used in the treatment of different liver diseases, especially chronic liver disease. It also has direct antiviral effects associated with intravenous administration in hepatitis C virus infection.

Online pharmacies face shortage

Currently, most hepatitis treatments are dispensed directly from hospital pharmacies.However, for years the association itself has claimed that such drugs should be able to be purchased pharmacies also sell Ensure patient comfort and convenience, thereby ensuring patient compliance (treatment adherence).

Although there may be substitutes for some medications, pharmacists do not have the authority to change a patient’s medication for another equivalent medication if a doctor has prescribed a specific one. Therefore, if a pharmacy is unable to fill a prescription due to a supply problem, The patient should go back to the doctor, inform him of the situation and ask him to change the prescription. Undoubtedly, this is a cumbersome, time-consuming process that directly affects patients with severe medical conditions.

In this context, the LUDA tool offers pharmacists the possibility to locate within seconds through technology, nearest pharmacy It can distribute medicines and help patients get them immediately, as it has already done for 160,000 patients, avoiding the fact that they have to return to the medical center, thereby reducing the burden on the health system.

Hepatitis is an inflammation of the liver that can lead to a range of health problems and can be fatal, according to the World Health Organization. The five main strains of hepatitis virus are A, B, C, D, and E. Although they all cause liver disease, they differ in important ways, notably mode of transmission, disease severity, geographic distribution, and treatment. prevention. Types B and C, in particular, are responsible for hundreds of millions of chronic diseases and together constitute the most common cause of death related to cirrhosis, cancer and viral hepatitis.

Source link

Leave a Comment